Enhanced Anticancer Activity of Nanoformulation of Dasatinib against Triple-Negative Breast Cancer.

Bahman, Fatemah; Pittalà, Valeria; Haider, Mohamed; Greish, Khaled

Bahman, Fatemah; Pittalà, Valeria; Haider, Mohamed; Greish, Khaled.

Afiliación

Bahman F; Department of Molecular Genetics, Kuwait Ministry of Health, Kuwait City 50000, Kuwait.
Pittalà V; Department of Drug and Health Science, University of Catania, 95125 Catania, Italy.
Haider M; Department of Pharmaceutics and Pharmaceutical Technology, College of Pharmacy, University of Sharjah, Sharjah 27272, United Arab Emirates.
Greish K; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 71526, Egypt.

J Pers Med ; 11(6)2021 Jun 15.

Article en En | MEDLINE | ID: mdl-34204015

Palabras clave

EPR; TNBC; dasatinib; metabolism; nanoformulation; nanomedicine; poly(styrene-co-maleic acid) micelles; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Pers Med Año: 2021 Tipo del documento: Article País de afiliación: Kuwait

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google